Thermo Fisher Acquires Clario for $8.875B, Expanding Cloud‑Based Clinical Data Services
Thermo Fisher’s $8.875 billion acquisition of Clario Holdings expands its clinical research services with cloud‑based data analytics, real‑time monitoring, and regulatory‑aligned data solutions, boosting CRS revenue and accelerating biopharma trials.
- Thermo Fisher Scientific Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read









